Ohcanbohtosat - Marius M. Hoeper

Aiddostahte ozu
  1. 1
    Pharmacological therapy for patients with chronic thromboembolic pulmonary hypertension

    Pharmacological therapy for patients with chronic thromboembolic pulmonary hypertension Dahkki Marius M. Hoeper

    Almmustuhtton 2015
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  2. 2
    Endothelin receptor antagonists in pulmonary arterial hypertension

    Endothelin receptor antagonists in pulmonary arterial hypertension Dahkki Jocelyn Dupuis, Marius M. Hoeper

    Almmustuhtton 2008
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  3. 3
    The new haemodynamic definition of pulmonary hypertension: evidence prevails, finally!

    The new haemodynamic definition of pulmonary hypertension: evidence prevails, finally! Dahkki Marius M. Hoeper, Marc Humbert

    Almmustuhtton 2019
    Viečča ollesdeavstta Viečča ollesdeavstta
    Editorial
    Lasit oiddohiidda
    Furkejuvvon:
  4. 4
    The revised definition of pulmonary hypertension: exploring the impact on patient management

    The revised definition of pulmonary hypertension: exploring the impact on patient management Dahkki Gérald Simonneau, Marius M. Hoeper

    Almmustuhtton 2019
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  5. 5
    Plasma coagulation profiles in patients with severe primary pulmonary hypertension

    Plasma coagulation profiles in patients with severe primary pulmonary hypertension Dahkki Marius M. Hoeper, Markus Sosada, H Fabel

    Almmustuhtton 1998
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  6. 6
    The changing landscape of pulmonary arterial hypertension and implications for patient care

    The changing landscape of pulmonary arterial hypertension and implications for patient care Dahkki Marius M. Hoeper, J. Simon R. Gibbs

    Almmustuhtton 2014
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  7. 7
    Gas exchange: the neglected piece in the PAH puzzle

    Gas exchange: the neglected piece in the PAH puzzle Dahkki Paul M. Hassoun, Rogério Souza, Marius M. Hoeper

    Almmustuhtton 2021
    Viečča ollesdeavstta Viečča ollesdeavstta
    Carta
    Lasit oiddohiidda
    Furkejuvvon:
  8. 8
    Medical management of chronic thromboembolic pulmonary hypertension

    Medical management of chronic thromboembolic pulmonary hypertension Dahkki Joanna Pepke‐Żaba, Hossein Ardeschir Ghofrani, Marius M. Hoeper

    Almmustuhtton 2017
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  9. 9
    Systemic Consequences of Pulmonary Hypertension and Right-Sided Heart Failure

    Systemic Consequences of Pulmonary Hypertension and Right-Sided Heart Failure Dahkki Stephan Rosenkranz, Luke Howard, Mardi Gomberg‐Maitland, Marius M. Hoeper

    Almmustuhtton 2020
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  10. 10
    Chronic Thromboembolic Pulmonary Hypertension

    Chronic Thromboembolic Pulmonary Hypertension Dahkki Marius M. Hoeper, Eckhard Mayer, Gérald Simonneau, Lewis J. Rubin

    Almmustuhtton 2006
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  11. 11
    Liver toxicity of sitaxentan in pulmonary arterial hypertension

    Liver toxicity of sitaxentan in pulmonary arterial hypertension Dahkki Nazzareno Galiè, Marius M. Hoeper, J. Simon, Richard Gibbs, Gérald Simonneau

    Almmustuhtton 2011
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  12. 12
    Carbon monoxide diffusing capacity and the complexity of diagnosis in pulmonary arterial hypertension

    Carbon monoxide diffusing capacity and the complexity of diagnosis in pulmonary arterial hypertension Dahkki Rogério Souza, Caio Júlio César dos Santos Fernandes, Marius M. Hoeper

    Almmustuhtton 2014
    Viečča ollesdeavstta Viečča ollesdeavstta
    Carta
    Lasit oiddohiidda
    Furkejuvvon:
  13. 13
    Goal-oriented treatment and combination therapy for pulmonary arterial hypertension

    Goal-oriented treatment and combination therapy for pulmonary arterial hypertension Dahkki Marius M. Hoeper, Iana Markevych, Edda Spiekerkoetter, Tobias Welte, J Niedermeyer

    Almmustuhtton 2005
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  14. 14
    Bosentan treatment in patients with primary pulmonary hypertension receiving nonparenteral prostanoids

    Bosentan treatment in patients with primary pulmonary hypertension receiving nonparenteral prostanoids Dahkki Marius M. Hoeper, Nasser Mohammed Taha, A. Bekjarova, R. Gatzke, Edda Spiekerkoetter

    Almmustuhtton 2003
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  15. 15
    Combination therapy with bosentan and sildenafil in idiopathic pulmonary arterial hypertension

    Combination therapy with bosentan and sildenafil in idiopathic pulmonary arterial hypertension Dahkki Marius M. Hoeper, Cornelia Faulenbach, Heiko Golpon, Jürgen Winkler, Tobias Welte, J Niedermeyer

    Almmustuhtton 2004
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  16. 16
    The ‘Ten Commandments’ of the 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

    The ‘Ten Commandments’ of the 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension Dahkki Stephan Rosenkranz, Marion Delcroix, George Giannakoulas, Marius M. Hoeper, Gábor Kovács, Marc Humbert

    Almmustuhtton 2023
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  17. 17
    Results of European post-marketing surveillance of bosentan in pulmonary hypertension

    Results of European post-marketing surveillance of bosentan in pulmonary hypertension Dahkki Marc Humbert, Eleanor S Segal, David G. Kiely, Joern Carlsen, Barbara Schwierin, Marius M. Hoeper

    Almmustuhtton 2007
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  18. 18
    An epidemiological analysis of the burden of chronic thromboembolic pulmonary hypertension in the USA, Europe and Japan

    An epidemiological analysis of the burden of chronic thromboembolic pulmonary hypertension in the USA, Europe and Japan Dahkki Henning Gall, Marius M. Hoeper, Manuel J. Richter, William Cacheris, Barbara Hinzmann, Eckhard Mayer

    Almmustuhtton 2017
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  19. 19
    Safety Experience With Bosentan in 146 Children 2–11 Years Old With Pulmonary Arterial Hypertension: Results from the European Postmarketing Surveillance Program

    Safety Experience With Bosentan in 146 Children 2–11 Years Old With Pulmonary Arterial Hypertension: Results from the European Postmarketing Surveillance Program Dahkki Maurice Beghetti, Marius M. Hoeper, David G. Kiely, Joern Carlsen, Barbara Schwierin, Eleanor S Segal, Marc Humbert

    Almmustuhtton 2008
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  20. 20
    C-reactive protein and procalcitonin for antimicrobial stewardship in COVID-19

    C-reactive protein and procalcitonin for antimicrobial stewardship in COVID-19 Dahkki Isabell Pink, David Raupach, Jan Fuge, Ralf‐Peter Vonberg, Marius M. Hoeper, Tobias Welte, Jessica Rademacher

    Almmustuhtton 2021
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:

Ohcanreaiddut: